美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件: 药品名称=AVANDARYL
符合检索条件的记录共5
1 页 当前第 1 页  返回检索页
1药品名称AVANDARYL
申请号021700产品号001
活性成分GLIMEPIRIDE; ROSIGLITAZONE MALEATE市场状态停止上市
剂型或给药途径TABLET;ORAL规格1MG;4MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期2005/11/23申请机构SB PHARMCO PUERTO RICO INC
2药品名称AVANDARYL
申请号021700产品号002
活性成分GLIMEPIRIDE; ROSIGLITAZONE MALEATE市场状态停止上市
剂型或给药途径TABLET;ORAL规格2MG;4MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期2005/11/23申请机构SB PHARMCO PUERTO RICO INC
3药品名称AVANDARYL
申请号021700产品号003
活性成分GLIMEPIRIDE; ROSIGLITAZONE MALEATE市场状态停止上市
剂型或给药途径TABLET;ORAL规格4MG;4MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期2005/11/23申请机构SB PHARMCO PUERTO RICO INC
4药品名称AVANDARYL
申请号021700产品号004
活性成分GLIMEPIRIDE; ROSIGLITAZONE MALEATE市场状态停止上市
剂型或给药途径TABLET;ORAL规格2MG;8MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期2007/03/30申请机构SB PHARMCO PUERTO RICO INC
5药品名称AVANDARYL
申请号021700产品号005
活性成分GLIMEPIRIDE; ROSIGLITAZONE MALEATE市场状态停止上市
剂型或给药途径TABLET;ORAL规格4MG;8MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期2007/03/30申请机构SB PHARMCO PUERTO RICO INC